Aliflurane (code name Hoechst Compound 26 or 26-P) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1][2][3][4]
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C4H3ClF4O |
| Molar mass | 178.51 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
See also
editReferences
edit- ^ World Health Organization (1988). International Nonproprietary Names (INN) for Pharmaceutical Substances. W.H.O. ISBN 9789240560369.
- ^ Banks RE, Smart BE, Tatlow JC (30 September 1994). Organofluorine Chemistry: Principles and Commercial Applications. Springer Science & Business Media. pp. 550–. ISBN 978-0-306-44610-8.
- ^ Kirsch P (6 March 2006). Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications. John Wiley & Sons. pp. 263–. ISBN 978-3-527-60419-7.
- ^ Kaushik (1995). Anaesthesia:Concepts and Management. Jaypee Brothers Publishers. pp. 124–. ISBN 978-81-7179-406-5.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |